Literature DB >> 7175448

Lactate dehydrogenase of Xenopus laevis laevis and Xenopus borealis depends on a multiple gene system.

J Wolff, H R Kobel.   

Abstract

Lactate dehydrogenase isozymes have been reinvestigated in Xenopus laevis laevis and Xenopus borealis. High resolution zymograms of various organs demonstrate that in both species the LDH isozymes are governed basically by a three-gene system: Ldh-a coding for positively charged polypeptide, and Ldh-b and Ldh-c for negatively charged polypeptides (at pH 8.9). These three LDH subunits when assembled in tetramers show differential sensitivity to heat inactivation; the C4 homotetramer is the most labile isozyme. Xenopus is thus similar to Osteichthyes, birds, and mammals that also have a three-gene system for LDH. With respect to tissue specific isozyme expression, Xenopus resembles the more primitive families of bony fish. Superimposed on this three-gene system is a probable gene duplication for both LDH-a and Ldh-b. Heterotetrameric isozymes are formed between the various subunits leading to multibanded zymograms with a total of at least 21 distinct zones of LDH activity. The expression of genes is tissue specific not only for the basic genes, but also for their presumed duplicates. Since both species of Xenopus are ancient tetraploids, duplication of Ldh genes is not surprising.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7175448     DOI: 10.1002/jez.1402230302

Source DB:  PubMed          Journal:  J Exp Zool        ISSN: 0022-104X


  2 in total

1.  Evolutionary relationships of lactate dehydrogenases (LDHs) from mammals, birds, an amphibian, fish, barley, and bacteria: LDH cDNA sequences from Xenopus, pig, and rat.

Authors:  S Tsuji; M A Qureshi; E W Hou; W M Fitch; S S Li
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

2.  The expression of creatine kinase isozymes in Xenopus tropicalis, Xenopus laevis laevis, and their viable hybrid.

Authors:  E Bürki
Journal:  Biochem Genet       Date:  1985-02       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.